Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.
It's been a volatile year for the company, but don't let that scare you away.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the questions I get more than any other is, “Jonathan, how do you ...
Vertex Pharmaceuticals is buying an endocrine treatment specialist for $10 billion.
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Biotech is the story at midday Friday, and it’s not a pretty one for shareholders who chased the sector’s monster 2026 run.
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large ...
Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse ...
That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results